Compare MATV & OFIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MATV | OFIX |
|---|---|---|
| Founded | 1995 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Paper | Medical/Dental Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 494.1M | 473.3M |
| IPO Year | 1996 | 1998 |
| Metric | MATV | OFIX |
|---|---|---|
| Price | $9.34 | $11.72 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $17.25 |
| AVG Volume (30 Days) | ★ 325.7K | 250.3K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | ★ 4.24% | N/A |
| EPS Growth | N/A | ★ 29.39 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $822,312,000.00 |
| Revenue This Year | $2.97 | $6.13 |
| Revenue Next Year | $4.20 | $6.22 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 2.85 |
| 52 Week Low | $5.46 | $10.25 |
| 52 Week High | $15.48 | $16.99 |
| Indicator | MATV | OFIX |
|---|---|---|
| Relative Strength Index (RSI) | 50.37 | 42.81 |
| Support Level | $8.02 | $10.94 |
| Resistance Level | $9.99 | $13.96 |
| Average True Range (ATR) | 0.42 | 0.61 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 60.86 | 22.58 |
Mativ Holdings Inc is a leader in specialty materials, solving its customers' complex challenges by engineering bold, inventive solutions that connect, protect, and purify the world. The company operates in two segments, namely Filtration & advanced Materials, focused on filtration media and components, developed films, coating and converting solutions, and extruded mesh products, and (2) Sustainable & Adhesive Solutions (SAS), focused on tapes, labels, liners, specialty paper, packaging, and healthcare solutions.
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.